Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. finds first cases of South African COVID-19 variant, in South Carolina

Published 01/28/2021, 11:59 AM
Updated 01/28/2021, 02:35 PM
© Reuters. A healthcare worker prepares a coronavirus test in Elizabeth, New Jersey

By Julie Steenhuysen

(Reuters) - The United States has found its first cases of a potent coronavirus variant first detected in South Africa, health officials in the state of South Carolina said on Thursday.

Viruses mutate frequently, and several mutated viruses have been identified. The presence of the South African variant in the United States is especially concerning because several laboratory studies have shown that it reduces vaccine effectiveness.

Another concern, according to the nominee for U.S. surgeon general, is that the South African variant could require larger doses of antibody for treatment.

"The thing that's troublesome now that we really need to keep our eye on are these variants," Anthony Fauci, the leading U.S. infectious disease specialist, said in an interview on MSNBC. "The one that is of greater concern and that really could be problematic is the mutant that is now dominant in South Africa."

So far, vaccines made by Moderna (NASDAQ:MRNA) Inc and Pfizer (NYSE:PFE) Inc/BioNTech appear protective against this variant of the coronavirus, despite the weaker response. The companies this week said they are considering making new versions of their shots just in case. Moderna also plans to test giving a third shot of its vaccine to bolster antibody levels. [nL1N2K329K]

The U.S. Centers for Disease Control and Prevention said in a statement that it is aware of the cases and noted that there is no evidence the variant causes more severe disease.

The arrival of the South African variant follows predictions by the CDC this month that a more-transmissible U.K. variant could become the dominant strain in the United States by March.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The South Carolina Department of Health and Environmental Control said the two cases of the B.1.351 variant of South African origin appear to be unrelated to one another.

The department said neither of the two adults had a travel history that would account for the infection.

Although the variant has been detected in more than 30 countries, the South Carolina cases were the first in the United States, it said.

"I'm very worried about the variants, all of them, all have the potential to be much more transmissible than the current version of COVID that we seem to be dealing with in the United States," U.S. Surgeon General nominee Vivek Murthy said in a Washington Post interview.

The CDC has said the arrival of more transmissible coronavirus variants emphasizes the need for rapid rollout of the vaccine to limit the ability of the virus to continue mutating.

Fauci said the U.S. had a "very serious issue" in the number of infections but was seeing some good news in plateauing cases and efforts to ramp up vaccinations.

Another variant originally detected in the United Kingdom, called B.1.1.7, has been detected in at least 28 states, according to CDC data.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.